Wangchung, zyl looks horrific. I on the other hand have enjoyed my ride in dml over the years. Mad will follow suit purely based on strong fundamentals that will get stronger this year.
MSB Mesoblast resubmits US FDA application for approval of Ryoncil in children with graft vs host disease; shares dip -4%